ZNF167 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.242100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.128200E-01
Normal-vs-Stage2
2.796000E-04
Normal-vs-Stage3
1.040490E-03
Normal-vs-Stage4
6.588300E-02
Stage1-vs-Stage2
1.554030E-01
Stage1-vs-Stage3
5.831600E-02
Stage1-vs-Stage4
3.460600E-01
Stage2-vs-Stage3
2.159000E-01
Stage2-vs-Stage4
7.392000E-01
Stage3-vs-Stage4
2.972200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.883300E-03
Normal-vs-AfricanAmerican
2.236800E-03
Normal-vs-Asian
6.640700E-03
Caucasian-vs-AfricanAmerican
4.218800E-01
Caucasian-vs-Asian
6.332200E-01
AfricanAmerican-vs-Asian
6.628600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.196200E-04
Normal-vs-Female
1.416050E-02
Male-vs-Female
4.957600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.405200E-01
Normal-vs-Age(41-60Yrs)
2.164700E-03
Normal-vs-Age(61-80Yrs)
4.361600E-03
Normal-vs-Age(81-100Yrs)
2.220300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.214760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.630100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.648500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.542500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.620300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.617000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.360100E-04
Normal-vs-Daily Drinker
3.81099999999801E-05
Normal-vs-Weekly Drinker
4.206200E-04
Normal-vs-Occasional Drinker
2.060400E-01
Normal-vs-Social Drinker
3.433500E-02
Non Drinker-vs-Daily Drinker
2.940800E-01
Non Drinker-vs-Weekly Drinker
9.301400E-01
Non Drinker-vs-Occasional Drinker
2.149600E-01
Non Drinker-vs-Social Drinker
1.601960E-01
Daily Drinker-vs-Weekly Drinker
3.889600E-01
Daily Drinker-vs-Occasional Drinker
8.526100E-02
Daily Drinker-vs-Social Drinker
3.354100E-02
Weekly Drinker-vs-Occasional Drinker
2.093600E-01
Weekly Drinker-vs-Social Drinker
2.094800E-01
Occasional Drinker-vs-Social Drinker
7.790000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.588400E-01
Normal-vs-Grade 2
3.577200E-01
Normal-vs-Grade 3
3.707800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.359800E-01
Grade 1-vs-Grade 3
4.844200E-01
Grade 1-vs-Grade 4
4.588400E-01
Grade 2-vs-Grade 3
6.747400E-01
Grade 2-vs-Grade 4
3.577200E-01
Grade 3-vs-Grade 4
3.707800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.61170000000067E-05
Normal-vs-NonDiabetic
3.700300E-03
Diabetic-vs-NonDiabetic
2.928600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.245400E-04
Normal-vs-NoPancreatitis
2.502100E-03
Pancreatitis-vs-NoPancreatitis
2.895400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.190100E-02
Normal-vs-N1
3.005300E-04
N0-vs-N1
5.436000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.248200E-04
Normal-vs-TP53-NonMutant
1.089770E-01
TP53-Mutant-vs-TP53-NonMutant
9.380100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
